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ABSTRACT 
Objective To estimate the burden of disease and related direct medical cost of 
Acute Respiratory Infections (ARI) for the health-care system in a low-income dis-
trict of Bogota, generated by children under age five and senior population over 
age sixty.
Methods A cross-sectional, retrospective, patient level study was conducted in 
San Cristobal district from 2008 to 2012 among the subsidized population. All in-
patients and outpatients with ARI from three hospitals were reported. The total and 
average direct medical costs were estimated and are reported in International Do-
llars (Int$).
Results It is estimated that, for children, ambulatory incidence rate for ARI varied 
between 54.4 % and 66.3 % and hospitalization rate between 9.2 % and 12.3 %. 
The mortality rate in the district oscillated between 18.1 and 27.7 deaths per 100 
000. The main medical costs were attributed to hospitalizations, and the total medi-
cal hospitalization cost per year estimated ranged between Int$ 1 334 352 and Int$ 
2 139 597. In the case of senior population, the ambulatory incidence rate fluctua-
ted between 7.6 % and 10.0 %, and the hospitalization rates between 0.6 % and 
2.1 %; the mortality rate ranged between 8.9 and 47.8 deaths per 100 000. Hospi-
talization cost per year was estimated to be between Int$ 88 957 and Int$ 373 382. 
Conclusion Direct medical costs due to ARI have an important disease and direct 
medical cost burden in this low-income district. 
Key Words: Colombia, respiratory tract infections, cost of illness, poverty areas 
(source: MeSH, NLM).
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RESUMEN 
Objetivo Estimar la carga de enfermedad y los costos médicos directos relacio-
nados con las Infecciones Respiratorias Agudas (IRA) para el sistema de salud 
en una localidad de bajos ingresos de Bogotá, en niños menores de cinco años y 
adultos mayores de sesenta años. 
Métodos Se realizó un estudio retrospectivo transversal a nivel de paciente en la 
localidad de San Cristóbal desde 2008 y 2012 en la población subsidiada. Se re-
portaron todos los pacientes hospitalizados y ambulatorios de tres hospitales pú-
blicos debido a IRA. Se estimaron los costos médicos directos relacionados. Los 
costos fueron convertidos en dólares internacionales (Int$).
Resultados En niños. Se estimó que la incidencia ambulatoria para IRA varió en-
tre 54,4 % y 66,3 % y la tasa de hospitalización varió entre 9,2 % y 12,3 %. La tasa 
de mortalidad en el distrito osciló entre 18,1 y 27,7 muertes por 100 000 niños. Se 
estimó que el costo de las hospitalizaciones oscilaron anualmente entre Int$ 1 334 
352 y Int$ 2 139 597 representado la más importante carga financiera. En adultos, 
la incidencia ambulatoria fluctuó entre 7,6 % y 10 %. Las tasas de hospitalización 
variaron entre el 0,6 % y el 2,1 %. Mientras que la tasa de mortalidad varió entre 
8,9 y 47,8 muertes por 100 000. Para hospitalizaciones se estimó un costo total por 
año entre Int$ 88 957 y Int$ 373 382. 
Conclusión Los costos médicos debido a IRA tienen una carga económica impor-
tante para el sistema de salud y los hogares en esta localidad. 
 
Palabras Clave: Colombia, infecciones del sistema respiratorio, costo de enferme-
dad, áreas de pobreza, Colombia (fuente: DeCS, BIREME).
Worldwide, disease burden caused by Acute Respiratory Infections (ARI) in 2011 was estimated at 117 million Disability Adjusted Life Years and 2.8 million deaths (1,2). ARI are among the lea-
ding causes of death in children but diagnosis and attribution are difficult 
(3). ARIs represent an important economic burden (4). 
In Colombia, from 2007 to 2011, the number of reported ARI increased, 
as well as the number of fatalities. In 2011, a cumulative total of 4,168,783 
ARIs cases were reported by the national surveillance system (Sistema 
Nacional de Vigilancia en Salud Pública) and approximately 706 fatalities 
were reported in children under five years of age (5). The etiology of ARI 
is given by a diverse group of bacteria and viruses (6). 
In 2010, the incidence of respiratory viruses, according to the Colombian 
National Institute of Health (Instituto Nacional de Salud, INS) showed that 
the respiratory syncytial virus caused 62 % of the cases studied, followed 
by influenza viruses (24 %) and parainfluenza viruses (8 %). Children are 
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the most affected group (7). Another age group highly vulnerable to ARI is 
senior population, causing hospitalizations and mortalities (8). 
ARIs are one of the main causes of hospitalization, generating an impor-
tant health utilization and absenteeism, therefore, impacting the economic 
system (3,6,9-12). In 2012, nationally, the associated mortality for ARIs 
was estimated at 13.35 deaths per 100,000 children under five (13).
There is limited data about the direct medical and epidemiological 
burden of these infections, especially among the low-income population 
(12,14,15). Understanding the direct medical cost of ARIs is important in 
order to prioritize a more efficient health intervention to decrease the eco-
nomic and disease burden. Therefore, the aim of this study is to estimate 
the direct medical cost of ambulatory and hospitalized cases of ARIs in a 
low-income district of Bogota, based on a population of children under five 
years of age and seniors over sixty years of age.
The population of Bogota accounts for more than 15 % of the country’s 
population. Located in Bogota, the district of San Cristobal had an esti-
mated population of 409,799 in 2011 (16). In 2012, the Gross National 
Income per capita was estimated at Int$ 4,758.01 for San Cristobal district 
only (16-19). Approximately 34.0 % of the population of San Cristobal is 
classified in the two lowest income strata of the country (16,17).
Similarly to the rest of the country, the health system of the population 
of San Cristobal is covered by two regimes: contributive and subsidized. 
The contributive system, representing 62.1 % of the district population, 
includes patients that can afford a premium rate. The subsidized regime, 
representing 37.9 % of the district population, consists of patients that are 
not able to pay a premium rate and are allowed to seek health services from 
public healthcare providers (12,17,20).    
METHODS
A cross-sectional retrospective study was conducted to assess the burden of 
disease and direct medical cost attributable to ARI between January 2008 
and December 2012, in children under five and seniors over sixty years, of 
the subsidized population, in three hospitals. These two age groups are at 
considerably higher risk of contracting ARIs and developing severe forms 
of the diseases (5,21,22). 
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The Individual Registry of Health Services (Registro Individual de Pres-
tación de Servicios or RIPS) was used, which include the following patient 
information: identification number, patient name, age, gender, home ad-
dress, insurance status (subsidized or contributive), purpose of the consul-
tation, treatment, start and end dates of treatment and medical diagnosis 
codified according to the International Statistical Classification of Diseases 
and Related Health Problems version 10 (ICD-10) (12,23). 
ARIs, according to the INS definition, are defined as “a group of infectious 
diseases caused by microorganisms that affect the upper and lower respiratory tract over a 
period of fifteen days, and can vary from a common cold to more severe complications such 
as pneumonia”. For this study, the guidelines of the INS to classify ARIs 
were used, taking into account the following ICD-10 codes (6, 24): 
• Acute infections of the upper respiratory tract: J00 to J06.
• Influenza (excluding influenza with pneumonia): J09, J10.1, J10.8, 
J11.1, J11.8.
• Pneumonia (including influenza with pneumonia): J10.0, J11.0 and J12 to J18 
• Other acute infections of the lower respiratory tract: J20 - J22.
The RIPS information from three public hospitals was analyzed, cove-
ring all patients within the subsidized system. The three hospitals corres-
pond to increasing levels of complexity: San Cristobal Hospital (first heal-
thcare level), San Blas Hospital (second healthcare level) and La Victoria 
Hospital (third healthcare level) (17). 
The total size of the subsidized population of the studied age groups was cal-
culated from estimations provided by the National Bureau of Statistics [Depar-
tamento Administrativo Nacional de Estadística] in 2012 (16,17). For both age 
groups, the burden of disease caused by ARIs was assessed using RIPS databa-
ses and the definition of burden of disease was restricted to the related morbidity 
and mortality of ARIs, and related ambulatory and hospitalized cases.
Using these individual patient records, the ICD-10 codes, the predefined 
time period and target population, patients with an ambulatory episode or 
hospitalization in one of the three hospitals were selected. The mortality 
rates for both groups caused by ARIs were estimated based on the mortali-
ty database of Bogota’s Health Services taking into account, for example, 
unspecified pneumonia as the main cause of death (25,26). 
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Direct medical costs caused by the disease include costs of visits, drugs 
and diagnostic tests. The number of visits could be derived from RIPS. 
Treatment procedure was taken from national guidelines and costs from 
the hospital standard procedure cost (27,28). Ambulatory cases were cate-
gorized in two groups: the first group. ARIs cases excluding pneumonias, 
it was assumed that both age groups were treated with antipyretics; the 
second group, including all causes of pneumonia, consisted of ICD 10 co-
des (J10.0, J11.0 and J12 to J18). It was also assumed that, for both age 
groups, diagnosis was obtained through thorax X-ray and patients were 
treated with antipyretics and antibiotics. The average cost per treatment for 
each age group and healthcare level was estimated. 
Data about hospitalizations, administered treatments and related direct 
costs (diagnostic, treatment, pharmaceutical and medical devices costs) 
registered in RIPS and retrieved for analysis were used to calculate the 
average cost per patient. The cost of treatment items included bed-cost 
per day, the physician’s salary, oxygen therapy and the cost of the Intensi-
ve Care Unit if applicable. The pharmaceutical cost included the different 
costs of antibiotics, antipyretics, nebulized bronchodilator therapies and 
other medications. 
In order to compare the different costs by year, all costs were converted 
to real prices in 2008. To convert nominal prices of a specific year during 
the period between 2008 and 2012 into real prices, the cumulative infla-
tion rate from 2008 until a specific year was applied (29). Colombian pe-
sos were then converted to international dollars Int$, using the purchasing 
power parity from the International Monetary Fund (30,31).
RESULTS
In the temperate climate of the northern hemisphere, ARIs have a clear seaso-
nal peak during winter (32,33). In this study, a consistent epidemiological peak 
in April, which historically is the rainiest month, was observed in children (32). 
The epidemiological peak is less pronounced (Figure 1.b) in senior population. 
During the pandemic A (H1N1) of 2009, the epidemiological peak emerged 
earlier in September and was more evident (Figure 1) in both age groups.
Children of the subsidized regime presented an ambulatory incidence be-
tween 54.4 % in 2012 and 66.3 % in 2009 (Table 1). Seniors of the subsidi-
zed regime presented an ambulatory incidence between 7.6 % in 2008 and 
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10.0 % in 2010 (Table 1). A hospitalization rate between 9.2 % in 2010 and 
12.3 % in 2012 (Table 1) was identified for children, and between 0.6 % in 
2008 and 2.1 % in 2012 for seniors (Table 1). The death rate varied between 
18.1 deaths and 27.7 deaths per 100,000 children in 2010 and 2012, respec-
tively, and for seniors, death rate ranged between 8.9 deaths and 47.8 deaths 
per 100,000 for the years 2008 and 2011, respectively (Table 1).
Figure 1. ARIs ambulatory cases. Children and seniors
a. ARIs ambulatory cases for children
b. ARIs ambulatory cases for seniors
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Table 1. ARIs Burden of disease for both age groups
Burden of disease 2008 2009 2010 2011 2012
Children under five
Total ambulatory cases 11.170 11.239 10.001 9.059 8.939
Total hospitalization cases 1.645 1.676 1.546 1.937 2.017
Total deaths 12 12 8 11 12
District population under five 45.344 44.736 44.166 43.820 43.366
Subsidized children population at district level 
(37.9 %) 17.185 16.955 16.739 16.608 16.436
Subsidized incidence ambulatory cases % 65.0 66.3 59.7 54.5 54.4
Subsidized hospitalization rate % 9.6 9.9 9.2 11.7 12.3
District mortality rate per 100. 000 children 26.5 26.8 18.1 25.1 27.7
Seniors over sixty
Total ambulatory cases 1.014 1.203 1.373 1.083 1.191
Total hospitalization cases 71 116 134 185 310
Total deaths 3 6 11 18 14
District population over sixty 33.577 34.919 36.345 37.652 39.028
Subsidized senior population district level (37.9 
%) 12.726 13.234 13.775 14.270 14.792
Subsidized incidence ambulatory cases % 8.0 9.1 10.0 7.6 8.1
Subsidized hospitalization rate 0.6 0.9 1.0 1.3 2.1
District mortality rate per 100. 000 seniors 8.9 17.3 30.3 47.8 35.9
For children, the average cost per ambulatory ARIs, excluding pneu-
monias, was estimated between Int$ 15.6 in 2012 and Int$ 26.9 in 2009. 
The average cost per ambulatory ARIs for all pneumonias was estimated 
between Int$ 45.2 in 2012 and Int$ 60.8 in 2009. For all ambulatory cases, 
a total cost per year was estimated between Int$ 209,174 in 2011 and Int$ 
284.570 in 2009. It was observed that the maximum value for the total cost 
occurred in 2009, during the influenza pandemic of A (H1N1). 
For seniors, the average cost per ambulatory ARI episode, excluding 
pneumonias, was estimated between Int$ 15.5 in 2012 and Int$ 24.9 in 
2009. The average cost per episode for all pneumonias was estimated be-
tween Int$ 43.0 in 2012 and Int$ 71.7 in 2008. For all ambulatory cases. 
a total cost per year was estimated between Int$ 29.631 in 2008 and Int$ 
46.774 in 2010. The average cost incurred per hospitalized child due to 
ARIs in first healthcare level hospitals was estimated between Int$ 228.5 
in 2009 and Int$ 280.5 in 2012. In second healthcare level hospitals. the 
average cost per hospitalized patient was estimated between Int$ 717.8 in 
2012 and Int$ 785.6 in 2008. Finally. in third healthcare level hospitals. 
the average was estimated between Int$ 1.067.5 in 2010 and Int$ 1.492 in 
2011 (Table 2). The total amount for the three hospitals was estimated per 
year between Int$ 1.334.352 in 2010 and Int$ 2.139.597 in 2011 (Table 2). 
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Table 2. Hospitalized children: average and total cost 
per healthcare level and year 
Description 2008 (%) 2009 (%) 2010 (%) 2011 (%) 2012 (%)
Level 1
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(4,1) 1 603,1   (4,1)
Total level 1 Int$ 47 750,6 50 734,0 40 337,6 49 290,2 38 711,7 38 711,7
Total number of 
cases 180 222 164 179 138 138
Average hospitalized 
cost Int$ 265,3 228,5 246.0 275,4 280.5 280.5
Level 2






















































(8.7) 51 525.6 (8.7)
Total level 2 Int$ 420 288,2 389 149,7 477 365,8 566 946,5 593 626.4 593 626.4
Total number of 
cases 535 518 617 737 827 827
Average hospitalized 
cost Int$ 785,6 751,3 773,7 769,3 717,8 717,8
Level 3






















































(2,8) 36 413,5 (2,8)
Total level 3 Int$ 1 012 588,5 1 049 041,5 816 648,4 1 523 360,1 1 299 413,7 1 299 413,7
Total number of 
cases 930 936 765 1 021 1 052 1 052
Average hospitalized 




627,4 1 488 925,3 1 334 351,9 2 139 596,7 1 931 751,8 1 931 751,8
For seniors hospitalized due to ARIs at first healthcare level hospitals, the 
average cost per patient was estimated between Int$528, 2 in 2010 and Int$582, 
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8 in 2008. For second healthcare level hospitals, the average cost per patient was 
estimated between Int$887, 1 in 2009 and Int$1,130in 2012. At the third heal-
thcare level hospitals, the average was estimated between Int$ 1,352.5 in 2012 
and Int$2,440.5 in 2010 (Table 3). For the three hospitals, the total cost per year 
was estimated between Int$88,957 in 2008 and Int$373,382 in 2012 (Table 3).
Table 3. Hospitalized seniors: average and total cost per healthcare level and year
Description 2008 (%) 2009 (%) 2010 (%) 2011 (%) 2012 (%)
Level 1




































Total level 1 Int$ 2,331.1 6,060.9 5,538.9 8,168.4 6,607.8
Total number of cases 4 11 11 15 12
Average hospitalized cost Int$ 582.8 551.0 503.5 544.6 550.6
Level 2




































Total level 2 Int$ 18,680.1 17,742.2 41,248.4 38,006.9 184,184.2
Total number of cases 18 20 40 40 163
Average hospitalized cost Int$ 1,037.8 887.1 1,031.2 927.0 1,130.0
Level,3


































Total level3 Int$ 67,945.9 145,991.5 202,559.0 217,339.0 182,590.2
Total number of cases 49 85 83 129 135
Average hospitalized cost Int$ 1,386.7 1,717.6 2,440.5 1,684.8 1,352.5
Total hospitalized costs Int$ 88,957.1 169,794.6 249,616.3 263,514.3 373,382.2
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DISCUSSION
Few studies have been conducted to calculate the average cost or yearly direct 
medical cost caused by ARIs. To the extent of our knowledge, this is the first study 
that correlates direct economic costs to an epidemiological burden in Colombia. 
For both age groups, we observed that the incidence of ambulatory ARI epi-
sodes followed a seasonal pattern with one peak corresponding to the rainy pe-
riod in April (Figure 1). This seasonal pattern offers us trustful consistency of 
the data. Furthermore, the yearly incidence of ambulatory cases for both age 
groups has a decreasing trend over the study period, especially for children, 
reaching its lowest level in 2012 (Table 1). Regarding yearly hospitalization 
rates, an increase in both age groups was noticed, reaching a maximum rate in 
2012 for children (Table 1), for whom an overall increase in mortality rate at the 
district level with a value of 27.7 per 100,000 children was found. This value 
is higher than the national level of 13.45 per 100,000 children in 2012 (13, 26). 
In the subsidized population, the mortality rate may be more relevant due to a 
higher presence of risk factors. In seniors, the trend in the number of ambulatory 
cases and deaths is not clear probably because of the presence of co-morbidities. 
In hospitalization cases, there is an increasing trend in the average and 
yearly total cost for both age groups, reaching a maximum level for chil-
dren, in 2011 and for seniors in 2012; these costs increases are driven by 
the tertiary healthcare level. 
Regarding hospitalization costs, compared to other national studies with 
children, we can see that our results of hospitalized pneumonia costs are 
close to the findings of Santamaria et al., of Int $1,525.3 (34) and Castane-
da-Orjuela et al. of USD $1,175 (9). For seniors, our results of hospitalized 
cases are consistent with the ones by Ordonez et al. of USD $1,932 (35).
Taking into account only the subsidized population is a limitation of 
these results, as well as the use of administrative data. ARI cases were 
selected based on the ICD-10 registration in the RIPS database and the 
records of cause of death in the mortality database, nonetheless, the stren-
gth of the administrative data is the inclusion of all subsidized population. 
A further limitation is that, for ambulatory cases, the average cost was 
calculated based on national medical protocols and not on patient records, 
which underestimates the direct ambulatory cost. To simplify our findings 
for the hospitalized costs, we calculated the average cost, which limited the 
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statistical distribution of the data. Also, direct medical and indirect costs 
spent by households were not considered since these costs could represent 
a high economic burden for households.
In order to diminish the impact of ARIs and other diseases caused by 
pneumococcus and seasonal influenza viruses. Colombia introduced a 
Pneumococcal Conjugated Vaccine in 2009 for children (37). Similarly, 
the seasonal influenza vaccine was included in 2009 in the national immu-
nization schedules for children under 60 months old (38). For population 
aged 60 and older, the influenza vaccine was introduced in 2009 (38) and 
the pneumococcal polysaccharide vaccine in 2011 (10). 
Despite the introduction of these vaccines, increases in hospitalization rates, 
mortality rates and related direct medical costs due to ARI in these two age 
groups were observed. Our analyses require better surveillance data in order 
to typify the pathogens that cause the disease burden of ARIs. Additional stu-
dies are also needed to provide a better understanding of the immunization 
campaigns including effectiveness, vaccines serotype coverage and timeliness. 
Finally, socioeconomic factors could contribute to the observed increases 
in severity and mortality due to ARIs. The increases in the severity in chil-
dren could be explained by the high percentage of young mothers with limited 
education and inadequate knowledge of prenatal and neonatal care (17,22). In 
this community, there are administrative and geographical barriers that could 
impede access to health facilities and treatments; the households could avoid 
bringing patients to health providers due to transportation costs and inadequate 
housing and sanitary conditions could also exacerbate the increase in severity 
of ARIs. In addition, San Cristobal district has experienced increases in rainfall 
levels in the past years, which may also explain the increases in severity of 
ARI.  Other factors, such as malnutrition in children, passive smoking and air 
pollution, may also be involved in the increase of the severity of ARIs. 
Direct medical costs of ARI represent an important economic burden on 
the subsidized health system of this community. The low-income stratum 
experiences a higher economic and disease burden than the national average 
stratum. Our findings highlight the need for further studies in the introduc-
tion of new vaccination strategies and evaluation of social, economic and 
environmental indicators related to economic and disease burden of ARI ♦
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